Bahrami Sima, Shafiee Fatemeh, Hakamifard Atousa, Fazeli Hossein, Soltani Rasool
Students Research Committee, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan, University of Medical Sciences, Isfahan, Iran.
Iran J Microbiol. 2021 Feb;13(1):50-57. doi: 10.18502/ijm.v13i1.5492.
Bacterial antibiotic resistance is one of the most important threats for public health around the world. Carbapenemase-producing Gram-negative bacteria have resistance to most antibiotics including carbapenems complicating the treatment of infections. The aim of this study was to determine the antimicrobial susceptibility pattern of carbapenemase-producing nosocomial Gram-negative pathogens at a referral teaching hospital to reveal the best options for treatment of related infections.
Gram-negative bacteria, isolated from hospitalized patients with nosocomial infections, underwent meropenem susceptibility test by disk diffusion method. Meropenem-resistant strains were evaluated for the presence of carbapenemase using Modified Hodge test (MHT). Finally, the antibiotic susceptibility test was performed to determine the sensitivity of each carbapenemase-positive strain against various antimicrobial agents according to the guidelines of Clinical and Laboratory Standards Institute (CLSI).
Over the study period, 155 carbapenemase-positive isolates were detected. Pneumonia was the most frequent related nosocomial infection (67.1%) followed by UTI (23.2%). (53.5%) and (40%) were the most frequently isolated pathogens. The pathogens had high rate of resistance to all antibiotics. Colistin had the most effect against all pathogens. Also, had a co-trimoxazole sensitivity rate equal to colistin (30.6%).
Carbapenemase-positive Gram-negative bacteria causing nosocomial infections are common in our hospital and have high rate of resistance to most antibiotics. Improvement in the pattern of antibiotic use and infection control measures are necessary to overcome this resistance.
细菌对抗生素的耐药性是全球公共卫生面临的最重要威胁之一。产碳青霉烯酶的革兰氏阴性菌对包括碳青霉烯类在内的大多数抗生素具有耐药性,这使得感染的治疗变得复杂。本研究的目的是确定一家转诊教学医院中产碳青霉烯酶的医院革兰氏阴性病原菌的抗菌药敏模式,以揭示治疗相关感染的最佳选择。
从医院感染的住院患者中分离出革兰氏阴性菌,采用纸片扩散法进行美罗培南药敏试验。使用改良 Hodge 试验(MHT)评估耐美罗培南菌株是否存在碳青霉烯酶。最后,根据临床和实验室标准协会(CLSI)的指南进行抗生素药敏试验,以确定每种碳青霉烯酶阳性菌株对各种抗菌药物的敏感性。
在研究期间,共检测到 155 株碳青霉烯酶阳性分离株。肺炎是最常见的相关医院感染(67.1%),其次是尿路感染(23.2%)。 (53.5%)和 (40%)是最常分离出的病原体。这些病原体对所有抗生素的耐药率都很高。黏菌素对所有病原体的疗效最佳。此外,复方新诺明的敏感率与黏菌素相同(30.6%)。
我院引起医院感染的碳青霉烯酶阳性革兰氏阴性菌很常见,对大多数抗生素的耐药率很高。有必要改进抗生素使用模式和感染控制措施以克服这种耐药性。